Before we launch into a discussion about more recent GLP-1 treatments and usages, I thought I would ask Ben Bikman to join us with his summary of a study about dietary fats and GLP-1 response: Dr
In the Satiety and Clinical AdiposityLiraglutide Evidence (SCALE) Diabetes trial, a total of 846 overweight and obese patients with T2D were randomly assigned to receive 3.0 or 1.8 mg of liraglutide or placebo for 56 weeks
Many patients find that this flexible, low-maintenance approach is actually easier to integrate into their lifestyle
Manufacturer discount programs can substantially lower monthly expenses, while alternative access methods provide additional pathways to affordability
Currently, our major research effort is to investigate the largest family of ubiquitin ligases, cullinRING ligases (CRLs)
This approach ensured that we captured all potential obesity-related prescriptions, while minimizing the risk of misclassifying prescriptions intended for other indications